Cargando…

The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs

The vast majority of reports on drug resistance deal with subtype B infections in developed countries, and this is largely due to historical delays in access to antiretroviral therapy (ART) on a worldwide basis. This notwithstanding the concept that naturally occurring polymorphisms among different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wainberg, Mark A., Brenner, Bluma G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390109/ https://www.ncbi.nlm.nih.gov/pubmed/22792462 http://dx.doi.org/10.1155/2012/256982

Ejemplares similares

Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs
por: Wainberg, Mark A., et al.
Publicado: (2010)

Substitutions in the Reverse Transcriptase and Protease Genes of HIV-1 Subtype B in Untreated Individuals and Patients Treated With Antiretroviral Drugs
por: Turner, Dan, et al.
Publicado: (2005)

Use of new resistance markers to predict virologic response to antiretrovirals
por: Wainberg, Mark A, et al.
Publicado: (2010)

HIV drug resistance against strand transfer integrase inhibitors
por: Anstett, Kaitlin, et al.
Publicado: (2017)

Highly diversified multiply drug-resistant HIV-1 quasispecies in PBMCs: a case report
por: Quan, Yudong, et al.
Publicado: (2008)

HIV-1 subtype C viruses rapidly develop K65R
por: Wainberg, Mark A, et al.
Publicado: (2006)

Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance
por: Xu, Hong-Tao, et al.
Publicado: (2009)

HIV-1 group O integrase displays lower susceptibility to raltegravir and has a different mutational pathway for resistance than HIV-1 group M
por: Depatureaux, Agnès, et al.
Publicado: (2014)

Does antiretroviral treatment change HIV-1 codon usage patterns in its genes: a preliminary bioinformatics study
por: Palanisamy, Navaneethan, et al.
Publicado: (2017)

Biochemical and virological analysis of the preference for the K65R multi-resistance nucleoside mutation in subtype C viruses
por: Wainberg, Mark A, et al.
Publicado: (2009)

A Template-Dependent Dislocation Mechanism Potentiates K65R Reverse Transcriptase Mutation Development in Subtype C Variants of HIV-1
por: Coutsinos, Dimitrios, et al.
Publicado: (2011)

Interactions of different drug resistance mutations in HIV Reverse Transcriptase in defining patterns of drug resistance
por: Wainberg, Mark A
Publicado: (2011)

Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in “Real-World” Settings
por: Brenner, Bluma G., et al.
Publicado: (2017)

The M50I polymorphic substitution in association with the R263K mutation in HIV-1 subtype B integrase increases drug resistance but does not restore viral replicative fitness
por: Wares, Melissa, et al.
Publicado: (2014)

A Significant Reduction in the Frequency of HIV-1 Drug Resistance in Québec from 2001 to 2011 Is Associated with a Decrease in the Monitored Viral Load
por: Charest, Hugues, et al.
Publicado: (2014)

Antiretroviral (ARV) Drug Resistance and HIV-1 Subtypes among Injecting Drug Users in the Coastal Region of Kenya
por: Ng'ong'a, Gabriel O., et al.
Publicado: (2022)

Comparative biochemical analysis of wildtype and drug resistant HIV-1 integrase subtypes B and C
por: Bar-Magen, Tamara, et al.
Publicado: (2009)

HIV and Drug-Resistant Subtypes
por: Nastri, Bianca Maria, et al.
Publicado: (2023)

Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy
por: Easterbrook, Philippa J, et al.
Publicado: (2010)

Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996–2008)
por: Martinez-Cajas, Jorge L, et al.
Publicado: (2009)

HIV Drug Resistance and Its Impact on Antiretroviral Therapy in Chinese HIV-Infected Patients
por: Xing, Hui, et al.
Publicado: (2013)

Phylogenetic Insights on Patterns of HIV-1 Spread and the Design of Epidemic Control Measures
por: Brenner, Bluma G.
Publicado: (2022)

The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance
por: Wainberg, Mark A.
Publicado: (2012)

Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance
por: Charpentier, Charlotte, et al.
Publicado: (2023)

HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure
por: van Hal, Sebastiaan J, et al.
Publicado: (2009)

Analysis of transmitted drug resistance, resistance mutations and future antiretroviral efficacy in HIV-1 subtype F infected-patients prior to therapy
por: Manolescu, LSC, et al.
Publicado: (2010)

Beyond Condoms: Risk Reduction Strategies Among Gay, Bisexual, and Other Men Who Have Sex With Men Receiving Rapid HIV Testing in Montreal, Canada
por: Otis, Joanne, et al.
Publicado: (2016)

Current Perspectives on HIV-1 Antiretroviral Drug Resistance
por: Iyidogan, Pinar, et al.
Publicado: (2014)

Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review
por: Bhargava, Madhavi, et al.
Publicado: (2014)

Comparative biochemical analysis of recombinant reverse transcriptase enzymes of HIV-1 subtype B and subtype C
por: Xu, Hong-Tao, et al.
Publicado: (2010)

Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapy
por: Wainberg, Mark A, et al.
Publicado: (2015)

Daily Variation in the Occurrence of Different Subtypes of Stroke
por: Ripamonti, Luciana, et al.
Publicado: (2017)

Geolocalization of HIV-1 subtypes and resistance mutations of patients failing antiretroviral therapy in Salvador – Brazil
por: Filho, Antonio Walter de Oliveira, et al.
Publicado: (2017)

PMTCT of HIV-1 in Burkina Faso: evaluation of residual vertical transmission by PCR, molecular characterization of subtypes and determination of antiretroviral drugs resistance
por: Sagna, T, et al.
Publicado: (2014)

Detection of minority drug resistant mutations in Malawian HIV-1 subtype C-positive patients initiating and on first-line antiretroviral therapy
por: Zhou, Zhiyong, et al.
Publicado: (2018)

Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria
por: El Bouzidi, Kate, et al.
Publicado: (2021)

HIV drug resistance and antiretroviral therapy programs in Henan, China
por: Liu, Zhi-Bin, et al.
Publicado: (2020)

HIV DNA Sequencing to Detect Archived Antiretroviral Drug Resistance
por: Geretti, Anna Maria, et al.
Publicado: (2022)

HIV-1 subtype diversity, drug resistance, and genetic transmission networks in men who have sex with men with virologic failure in antiretroviral therapy in Sichuan, China, 2011 to 2017
por: Yuan, Dan, et al.
Publicado: (2019)

Drug Resistance in Non-B Subtype HIV-1: Impact of HIV-1 Reverse Transcriptase Inhibitors
por: Singh, Kamalendra, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_msb0886iutuqts00m03fn7q7bk